Hotel-Dieu de Quebec

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Prostate cancer4 trials
• Ovarian cancer3 trials
• Head and neck cancer2 trials
• Melanoma2 trials
• Amyloidosis1 trial
• Heart failure1 trial

Phase

• Phase 35 trials
• Phase 24 trials

Status

• Active, not recruiting8 trials
• Recruiting4 trials

Lead sponsor

• Canadian Cancer Trials Group7 trials
• AstraZeneca2 trials
• Melanoma and Skin Cancer Trials Limited1 trial
• Novo Nordisk A/S1 trial
• University of Sydney1 trial

Running trials

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

  NCT06641791· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Patrick Martin

• Recruiting

  LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

  NCT06623461· Phase 2· Canadian Cancer Trials Group· Source

  Contact: Chloe Beland

• Active, not recruiting

  177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

  NCT04663997· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

  NCT04136353· Phase 3· University of Sydney· Source

• Recruiting

  Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  NCT03860883· Melanoma and Skin Cancer Trials Limited· Source

  Contact: Dr Cindy Boulanger-Gobeil

• Active, not recruiting

  Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

  NCT03784755· Canadian Cancer Trials Group· Source

• Active, not recruiting

  De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

  NCT03822897· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  ASA in Prevention of Ovarian Cancer (STICs and STONEs)

  NCT03480776· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

  NCT02960087· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

  NCT01874353· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

  NCT01844986· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma2 recruiting
• Amyloidosis1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting